Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Teruko Hino"'
Autor:
Tomoya Sano, Tatsuya Ide, Shirachi Miki, Teruko Hino, Naofumi Ono, Takuji Torimura, Toshihiro Kawaguchi, Reiichiro Kuwahara, Keisuke Amano
Publikováno v:
Molecular and Clinical Oncology
Advanced liver fibrosis is the most important risk factor for hepatocellular carcinoma (HCC) development after achieving sustained virological response (SVR) by direct-acting antiviral (DAA) treatment in patients with chronic hepatitis C. Wisteria fl
Autor:
Reiichiro Kuwahara, Takuji Torimura, Tomoya Sano, Hironori Koga, Teruko Hino, Keisuke Amano, Tatsuya Ide, Toshihiro Kawaguchi, Ryoko Kuromatsu
Publikováno v:
Biomedical Reports
The aim of the present study was to evaluate the effects of switching to tenofovir alafenamide (TAF) in patients who had received a nucleos(t)ide analog (NA) for the treatment of chronic hepatitis B (CHB). The data from 33 Japanese patients with CHB
Autor:
Keisuke Amano, Reiichiro Kondo, Reiichiro Kuwahara, Toshihiro Kawaguchi, Jun Akiba, Koichi Ohshima, Yoriko Nomura, Takuji Torimura, Tatsuya Ide, Hirohisa Yano, Tomoya Sano, Teruko Hino
Publikováno v:
Experimental and Therapeutic Medicine
Although the incidence of hepatocellular carcinoma (HCC) occurring after hepatitis C virus (HCV) eradication has decreased, there are still reports of hepatocarcinogenesis. The present study investigated the histological changes of non-cancerous live
Autor:
Teruko, Hino-Arinaga, Tatsuya, Ide, Ryoko, Kuromatsu, Ichiro, Miyajima, Kei, Ogata, Reiichiro, Kuwahara, Akiko, Hisamochi, Takuji, Torimura, Michio, Sata, Miki, Shirachi
Publikováno v:
Journal of Gastroenterology. 47:569-576
Hepatocellular carcinoma (HCC) is occasionally seen even in patients with autoimmune hepatitis (AIH) without prior infection either with hepatitis C virus (HCV) or hepatitis B virus. The aim of this study was to identify the incidence of and risk fac
Autor:
Akiko Hisamochi, Ryukichi Kumashiro, Yuriko Koga, Teruko Hino, Michio Sata, Tatsuya Ide, Kazuo Tanaka, Kei Ogata, Reiichiro Kuwahara, Yukari Takao, Hiroyuki Koga
Publikováno v:
Digestive Diseases and Sciences. 53:2999-3006
The aims of this study were to select the patients with a potential for progression to hepatic failure due to lamivudine-resistant HBV and to standardize the treatment for patients with lamivudine-resistant HBV. Patients (n = 47) with reactivated hep
Autor:
Kazuhiko Oho, Kazuo Tanaka, Kei Ogata, Atsushi Toyonaga, Tatsuya Ide, Reiichiro Kuwahara, Michio Sata, Teruko Hino, Ryukichi Kumashiro, Akiko Hisamochi, Hiroyuki Koga
Publikováno v:
Hepatology Research. 37:503-509
Aim: Many studies have reported the therapeutic effects of lamivudine on cirrhotic patients with hepatitis B; however, no study has investigated the morphological changes of esophageal varices after lamivudine treatment. Method: The morphological cha
Autor:
Michio Sata, Tatsuya Ide, Teruko Hino, Akiko Hisamochi, Ryukichi Kumashiro, Kei Ogata, Yuriko Koga, Kazuo Tanaka, Hiroyuki Koga, Reiichiro Kuwahara
Publikováno v:
Journal of Gastroenterology. 40:625-630
We evaluated the clinical course of patients with chronic hepatitis B who showed viral breakthrough during long-term lamivudine therapy.We initially studied 141 patients treated with lamivudine for 1 year or more, and 49 patients who showed viral bre
Predicting Relapse after Cessation of Lamivudine Monotherapy for Chronic Hepatitis B Virus Infection
Autor:
Teruko Hino, Kenji Sakakibara, Tatsuya Ide, Kiyoaki Ito, Haruhiko Nukaya, Ryukichi Kumashiro, Atunaga Kato, Ryuzo Ueda, Michio Sata, Etsuro Orito, Yasuhito Tanaka, Motokazu Mukaide, Masashi Mizokami, Hidemi Ito, Noboru Hirashima
Publikováno v:
Clinical Infectious Diseases. 38:490-495
There have been reports of relapse after cessation of lamivudine monotherapy for hepatitis B virus (HBV) infection. The aim of this study was to examine factors that predict posttreatment relapse. Comparison 22 patients who experienced relapse with 1
Autor:
Michio Sata, Hiroto Inoue, Ryukichi Kumashiro, Teruko Hino, Ryo Tanabe, Reiichiro Kuwahara, Tatsuya Ide, Eisuke Tanaka, Yuriko Koga
Publikováno v:
Digestive Diseases and Sciences. 49:300-303
Hepatitis B virus (HBV) infection is a serious worldwide problem because it is one of the major causes of cirrhosis and hepatocellular carcinoma in endemic areas. The number of people with chronic HBV infection is 350 million globally (1). Until rece
Autor:
Ryukichi KUMASHIRO, Teruko HINO, Yuriko KOGA, Akiko HISAMOCHI, Hidetoshi ARIMATSU, Reiichiro KUWAHARA, Hiroto KUMEMURA, Tatsuya IDE, Eisuke TANAKA, Michio SATA
Publikováno v:
Kanzo. 44:113-116